An Open Label, Multicenter Study to Evaluate the Pharmacokinetics, Efficacy and Safety of ASCENIV™ (IGIV) in Pediatric Subjects With Primary Immunodeficiency Diseases (PIDD)
Clinical trial NCT05070455 · UNKNOWN
Trial details
- NCT number
- NCT05070455
- Sponsor
- ADMA Biologics, Inc.
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2023-03-31
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.